INVESTMENTS - Additional Information (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2022
USD ($)
|
Jun. 30, 2023
USD ($)
entity
|
Jun. 30, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
|
|
Marketable Securities [Line Items] | |||||
Partnership and joint venture entities | entity | 181 | ||||
Investment income | $ (12,200) | $ 107,200 | $ (114,600) | $ 182,400 | |
Accrued performance recognized under equity method | (10,900) | $ 103,700 | (114,700) | $ 178,500 | |
Accrued performance allocations compensation | $ 47,529 | $ 47,529 | $ 66,754 | ||
Minimum | |||||
Marketable Securities [Line Items] | |||||
Accrued performance allocation percentage | 6.00% | ||||
Maximum | |||||
Marketable Securities [Line Items] | |||||
Accrued performance allocation percentage | 8.00% |
X | ||||||||||
- Definition Accrued Performance Allocation Reduction Percentage No definition available.
|
X | ||||||||||
- Definition Accrued performance allocations compensation. No definition available.
|
X | ||||||||||
- Definition Equity Method Investment, Accrued Performance Allocations No definition available.
|
X | ||||||||||
- Definition Number Of Partnerships And Joint Ventures No definition available.
|
X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|